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Primitive neuroectodermal tumors (PNETs) are a group of tumors from the phenotypic spectrum of Ewing’s family of tumors, originating from the neuroectoderm [1]. These are 
small-round cell, biologically aggressive and highly malignant 
tumors [1]. PNETs were originally defined in 1918 [2], but the 
first case of renal PNET was reported in 1975 [3] and very few 
cases of renal PNET with inferior vena cava (IVC) thrombus have 
been reported since [4]. Although there has been an increase in 
the reporting of this entity in the recent years due to improved 
immunohistochemistry and cytogenetic techniques of analysis, 
the prognosis remains poor, with the median disease-free survival 
of 5.0 months [4].
We report a case of renal PNET in a 23-year-old female from 
the left kidney, with thrombus extension into the IVC diagnosed 
by post-operative immunohistochemical analysis of the resected 
specimen.
CASE REPORT
A 23-year-old female presented with pain and a mass on the left 
side of the abdomen for 4 months. The pain was progressive in 
nature. There was no history of fever, dyspnea, nausea, vomiting, 
diarrhea, hematuria, or change in bowel/bladder habits. On 
examination, the patient was calm, conscious, and afebrile, with 
stable vitals. The abdomen was soft, non-tender, and not distended. 
A solid, firm, mobile mass was palpable in the left lumbar region, 
about 20 cm ×15 cm, moving with respiration, non-ballotable, 
and non-tender. The mass had a smooth surface and the margins 
could not be properly delineated. Her other examinations were 
unremarkable.
The ultrasonography of the abdomen showed a large, 
retroperitoneal mass in the paraumbilical region, extending up to 
the left hypochondrium, with necrotic areas and calcifications, and 
increased vascularity on color Doppler. Computed tomography 
(CT) (Fig. 1) showed a heterogeneously enhancing, well-defined, 
lobulated mass, measuring 20.6 cm × 12.2 cm × 9.8 cm, in the 
left renal fossa, almost completely obliterating the left kidney, 
extending into the perinephric space, infiltrating the Gerota’s 
fascia, and crossing the midline anterior-superiorly, invading 
the left adrenal gland as well as presence of a thrombus in the 
renal vein, extending into the IVC, up to the intrahepatic portion. 
Multiple tortuous vessels were observed in the periphery of the 
mass, extending centrally. Based on the age group of the patient 
and the characteristics of the tumor described, the presumptive 
diagnosis of renal cell carcinoma was established.
Renal angiography with embolization of the tumor was done, 
through left superficial femoral artery under local anesthesia. 
Aortic angiography showed the blood supply to the tumor arising 
from branches of left renal artery and three collaterals from the 
abdominal aorta below the renal artery, two from thoracic aorta, 
and one from superficial epigastric artery. Embolization of all 
the feeders was done by selective cannulation using 6F JR 3.5 
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and propagate microcatheter over whisper wire, using polyvinyl 
chloride particles of 250-355 nm diameter. Post-procedure all 
feeders were embolized and no complications were observed.
The patient was taken up for radical left nephrectomy and 
removal of IVC thrombus under deep hypothermic circulatory 
arrest (Fig. 2), under which the temperature of the body is lowered 
to 18°C on a heart-lung machine and the body tissue (especially 
brain) can withstand no blood circulation for 40 min duration, 
ensuring a bloodless field to undertake operations on major 
vessels. The entire involved kidney along with the tumor, and the 
IVC thrombus was removed completely. A few mesenteric lymph 
nodes were also resected. Following the surgery, the patient had 
an uneventful recovery, was extubated after 12 h, and ambulated 
on the 1st post-operative day.
The resected specimen along with the lymph nodes was sent 
for immunohistochemical analysis. The report described a brown 
mass measuring 26 cm × 15 cm × 9.5 cm, weighing 4 kg, with 
nodular external surface, solid-white cut surface with cystic and 
necrotic areas (Fig. 3a). Histology examination of the specimen 
showed small tumor cells arranged in Homer-Wright rosettes with 
hyperchromatic nuclei, scanty cytoplasm, and many apoptotic 
bodies (Fig. 3b). Immunostain analysis demonstrated diffuse 
membranous positivity for CD99. Reevaluation of the patient was 
done based on this report of the excised mass, and the diagnosis 
of renal PNET was established, as a Stage IV, T4N1M0.
Post-operative CT scan of the patient showed no residual 
mass in the left renal bed or IVC thrombus. The oncology team 
advised the patient to undergo adjuvant chemotherapy as per 
the vincristine, doxorubicin, and dexamethasone regimen for 
4-6 cycles, over 6 months from an outside center, as radiotherapy 
treatment was not available in authors’ hospital at the time. The 
patient was discharged on the 7th post-operative day in a stable 
condition, with a healthy wound and good saturation on room air. 
At 1-month follow-up, the patient was doing well, saturating 96% 
on room air, with healthy wounds. At the latest follow-up, the 
patient was due to start the chemotherapy in 2-week duration.
DISCUSSION
PNETs, along with Ewings’s sarcoma (ES) and asking tumors 
form ES/PNET family of tumors [5], are usually referred to 
interchangeably in the literature. When the first case of PNET was 
described by Stout in 1918 [2], they were thought to arise directly 
from nerves; however, more recently, the origin of renal PNETs has 
been postulated to be from the adrenergic fibers that invest in the 
renal tissue from celiac plexus or the neural crest cells that migrate 
to the kidney and undergo tumor genesis later in life [6]. Although 
these tumors are more common in the first two decades of life, with 
an incidence of 2.9 per million annually in this population [7], cases 
have been reported in all age groups [8]. Peripheral PNETs more 
commonly arise in the chest wall and paraspinal regions [9] and are 
very rarely seen in other soft tissues such as kidneys.
This tumor, when arising in the kidneys, presents with the 
symptoms of hematuria, bulky renal mass, and abdominal or 
flank pain, with one-third of the patients having renal vein or 
IVC thrombus at the time of diagnosis [4]. Grossly, these tumors 
may range from 3.3 to 18 cm in size, characterized with areas 
of necrosis and hemorrhage [4,10]. On light microscopy, these 
tumors appear as monotonous collection of small, round, darkly 
stained cells, and electron microscopy reveals neurosecretory 
granules with microtubules and filaments [7], with cells arranged 
in Flexner-Wintersteiner rosettes having well-defined central 
Figure 1: Pre-operative computed tomography scan of the patient, 
the red arrows showing the tumor growth of the left kidney
Figure 2: Intraoperative view
Figure 3: (a) Gross specimen, cut section. (b) Microscopic view of 
the specimen
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Lumina or as Homer-Wright rosettes with fibrillary cores [6]. 
The most commonly expressed immunohistochemistry markers 
are the proteins encoded by MIC2 gene, commonly CD99, 
O13 [8,11], with CD99 found to be positive in more than 90% 
of ES/PNET and Friend leukemia virus integration-1 (FLI-1) and 
antibody to FLI-1 seen in majority of cases [12]. Vimentin and 
neuron-specific enolase have also been found positive in more 
than 80% of cases [11].
Due to rarity of this entity, there is no standardized protocol of 
treatment but surgical excision of the primary tumor is undertaken 
for a majority of these patients. Neoadjuvant or adjuvant 
chemotherapy is given with multidrug therapy, commonly 
consisting of doxorubicin, vincristine, cyclophosphamide, 
ifosfamide, and etoposide [13]. Role of radiation therapy is not 
completely established but may be used for targeted treatment 
of positive lymph nodes following surgery [10]. Median overall 
survival of these patients has been estimated at 26.5 months [4].
This was a 23-year-old female, presenting with pain abdomen 
and a bulky abdomen mass arising on the left side of a few months 
duration, without any complaints of hematuria. According to 
the pre-operative CT, the tumor was a large mass, replacing the 
entire left kidney, invading the left adrenal mass, and crossing 
the midline. The histomorphology of the excised mass showed 
Homer-Wright rosettes and immunostain positivity for CD99. 
After undergoing surgical excision with thrombectomy, the 
post-operative CT scan of this patient did not show evidence of 
any residual disease, and the patient was subsequently advised 
chemotherapy for the metastatic disease.
CONCLUSION
The renal PNET with IVC thrombus is an extremely rare 
entity, presenting in advanced stages of the disease, posing a 
diagnostic challenge to the treating team of physicians, and 
having a dismal prognosis for the patient. Advanced techniques 
of immunohistochemical analysis along with high degree of 
suspicion and expertise of the physician are required to arrive 
at the correct diagnosis. Multidisciplinary team of physicians, 
in a tertiary care cenetr, is required for the adequate approach 
to management of the patient, as correct diagnosis and timely 
intervention can be highly valuable for a better prognosis of the 
patient.
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